Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05122728 · ClinicalTrials.gov registry record
Post-Concussion Musculoskeletal Injury Risks
A clinical trial of Musculoskeletal Injury, sponsored by Walter Reed National Military Medical Center.
- Recruiting
- Registry status
- 148
- Enrollment target
- 3
- Study locations
NCT05122728 is a study of Musculoskeletal Injury that is actively recruiting participants, run by Walter Reed National Military Medical Center. The registered enrollment target is 148 participants, below the 512-participant average among 15 other Musculoskeletal Injury trials with a reported enrollment target (71% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT05122728, a study of Musculoskeletal Injury, is actively recruiting participants, sponsored by Walter Reed National Military Medical Center.
- RECRUITING
- Registry status
- 148 participants
- Enrollment target
- 3
- Study locations
Study Summary
Musculoskeletal injuries (MSKI) and traumatic brain injury (TBI) are the signature injuries of the ongoing military conflicts. MSKI affect 800,000 Service Members annually and TBI have impacted more than 350,000 in the past 19 years and account for 22% of all combat casualties. Concussion, a mild form of TBI, increases MSKI risk in physically active individuals, including Service Members. The overall goal of the study is to identify the neuromuscular control mechanisms that increase MSKI risk following concussion. It is hypothesized that concussed individuals will display abnormal neuromuscular function that increases MSKI risk, as compared to non-concussed controls. The study will employ a multi-center, prospective, case-matched control observational study to identify the differences in neuromuscular function following concussion that may contribute to increased MSKI risk. Once the neuromuscular control mechanisms that increase MSKI risk following concussion are identified, targeted risk mitigation strategies can be developed to reduce MSKI risk.
Conditions Studied
Interventions
- OTHER Post-Concussion Neuromuscular Function and Musculoskeletal Injury Risk Assessment
Study Locations (3)
Georgia
- University of Georgia - Athens
Maryland
- Walter Reed National Military Medical Center - Bethesda
North Carolina
- Womack Army Medical Center - Fort Bragg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2022-10-20 |
| Est. Completion | 2027-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05122728
The ClinicalTrials.gov registry entry for NCT05122728 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 148 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 512-participant average among 15 other Musculoskeletal Injury trials with a reported enrollment target (71% lower). The listed sponsor is Walter Reed National Military Medical Center, which has 48 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Musculoskeletal Injury appearing as the primary indexed condition, and to 1 intervention - of which Post-Concussion Neuromuscular Function and Musculoskeletal Injury Risk Assessment is the first listed.
NCT05122728 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Georgia, Maryland, North Carolina.
Frequently Asked Questions
What is clinical trial NCT05122728 about?
NCT05122728 is a clinical study titled "Post-Concussion Musculoskeletal Injury Risks". Musculoskeletal injuries (MSKI) and traumatic brain injury (TBI) are the signature injuries of the ongoing military conflicts. MSKI affect 800,000 Service Members annually and TBI have impacted more than 350,000 in the past 19 years and account for 22% of all combat casualties. Concussion, a mild fo...
What is the current status of trial NCT05122728?
This trial is currently recruiting. The enrollment target is 148 participants. The study started on 2022-10-20. Estimated completion is 2027-09-30.
What conditions does trial NCT05122728 study?
This clinical trial studies the following conditions: Musculoskeletal Injury.
What interventions are being tested in trial NCT05122728?
The interventions under investigation include: Post-Concussion Neuromuscular Function and Musculoskeletal Injury Risk Assessment (OTHER).
Who is sponsoring clinical trial NCT05122728?
This trial is sponsored by Walter Reed National Military Medical Center, which has 48 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05122728 being conducted?
This trial has 3 study locations across Georgia, Maryland, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Musculoskeletal Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Effects of AFO Heel Height and Stiffness on Gait
RECRUITING · NA
-
Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma
RECRUITING · NA
-
Use of an Integrated Orthotic and Rehabilitation Initiative for Treatment of Lower Extremity Musculoskeletal Disorders
RECRUITING
-
Adaptions and Resiliency to Multi-Stressor OpeRations
RECRUITING · Phase 4
-
Quality of Life and Life Satisfaction in Pediatric and Adolescent Gymnasts Through Injury
RECRUITING
-
Baseline ACL Injury Risk Screening and Normative Data
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.